# Michael Kalos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-kalos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,621 |
| Field | CAR-T cell therapy research |
| h-index | 54 |
| i10-index | 96 |
| Last Known Institution | Pillar College |
| OpenAlex ID | https://openalex.org/A5037746795 |
| ORCID iD | https://orcid.org/0000-0002-1839-3194 |
| Works | 246 |

## Researcher papers

- [NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma](https://scholariq.org/papers/ny-eso-1-specific-tcr-engineered-t-cells-mediate-sustained-antigen-specific/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [Pillar College](https://scholariq.org/institutions/pillar-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.